H. Witzgall

552 total citations
31 papers, 420 citations indexed

About

H. Witzgall is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, H. Witzgall has authored 31 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in H. Witzgall's work include Hormonal Regulation and Hypertension (14 papers), Adrenal Hormones and Disorders (5 papers) and Renin-Angiotensin System Studies (4 papers). H. Witzgall is often cited by papers focused on Hormonal Regulation and Hypertension (14 papers), Adrenal Hormones and Disorders (5 papers) and Renin-Angiotensin System Studies (4 papers). H. Witzgall collaborates with scholars based in Germany, Italy and Canada. H. Witzgall's co-authors include Christian Weber, Reinhard Lorenz, Alois Sellmayer, R. Gerzer, Jolanta Gutkowska, Johanne Tremblay, Pavel Hamet, B. Scherer, Decio Armanini and Martin Wehling and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Applied Physiology and The American Journal of Cardiology.

In The Last Decade

H. Witzgall

31 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Witzgall Germany 11 143 131 100 95 68 31 420
G. F. Di Francesco Italy 5 125 0.9× 122 0.9× 78 0.8× 102 1.1× 25 0.4× 10 362
Donald D. Smyth Canada 16 130 0.9× 67 0.5× 47 0.5× 230 2.4× 51 0.8× 45 573
JS McLay United Kingdom 10 183 1.3× 59 0.5× 52 0.5× 87 0.9× 55 0.8× 18 415
R E McCaa Guatemala 11 210 1.5× 170 1.3× 128 1.3× 103 1.1× 27 0.4× 14 465
Hans J. Keim Germany 11 430 3.0× 194 1.5× 123 1.2× 205 2.2× 105 1.5× 14 728
J B Smith United States 6 169 1.2× 39 0.3× 63 0.6× 76 0.8× 135 2.0× 6 537
Louis Wj Australia 14 150 1.0× 74 0.6× 29 0.3× 133 1.4× 103 1.5× 29 547
F LEENEN Canada 14 437 3.1× 185 1.4× 96 1.0× 101 1.1× 71 1.0× 21 682
Z. Glück Switzerland 14 347 2.4× 245 1.9× 55 0.6× 96 1.0× 120 1.8× 24 671
G Di Maro Italy 10 62 0.4× 180 1.4× 120 1.2× 159 1.7× 48 0.7× 12 577

Countries citing papers authored by H. Witzgall

Since Specialization
Citations

This map shows the geographic impact of H. Witzgall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Witzgall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Witzgall more than expected).

Fields of papers citing papers by H. Witzgall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Witzgall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Witzgall. The network helps show where H. Witzgall may publish in the future.

Co-authorship network of co-authors of H. Witzgall

This figure shows the co-authorship network connecting the top 25 collaborators of H. Witzgall. A scholar is included among the top collaborators of H. Witzgall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Witzgall. H. Witzgall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sellmayer, Alois, H. Witzgall, Reinhard Lorenz, & Christian Weber. (1995). Effects of dietary fish oil on ventricular premature complexes. The American Journal of Cardiology. 76(12). 974–977. 90 indexed citations
2.
Wehling, Martin, J Heim, Rebecca Lorenz, et al.. (1989). Effects of clonidine and dihydralazine on atrial natriuretic factor and cGMP in humans. Journal of Applied Physiology. 67(3). 938–944. 3 indexed citations
3.
Wehling, Martin, Ursula Kuhnle, H. Witzgall, P. C. Weber, & Decio Armanini. (1988). LACK OF EFFECT OF ALDOSTERONE ON INTRACELLULAR SODIUM AND POTASSIUM IN MONONUCLEAR LEUCOCYTES FROM PATIENTS WITH PSEUDOHYPOALDOSTERONISM. Clinical Endocrinology. 28(1). 67–74. 15 indexed citations
4.
Wehling, Martin, et al.. (1987). Effects of aldosterone on intralymphocytic sodium and potassium in patients with primary aldosteronism. European Journal of Endocrinology. 116(4). 555–560. 5 indexed citations
5.
Heim, J, et al.. (1986). Effects of Clonidine and Dihydralazine on Plasma ANF and Cyclic GMP Levels in Humans During Volume Loading. Journal of Cardiovascular Pharmacology. 10. S163–S166. 2 indexed citations
6.
Witzgall, H. & Jürgen Behr. (1986). Effects of Potassium Loading in Normal Man on Dopaminergic Control of Mineralocorticoids and Renin Release. Journal of Hypertension. 4(2). 201–205. 7 indexed citations
7.
Gerzer, R., H. Witzgall, Johanne Tremblay, Jolanta Gutkowska, & Pavel Hamet. (1985). RAPID INCREASE IN PLASMA AND URINARY CYCLIC GMP AFTER BOLUS INJECTION OF ATRIAL NATRIURETIC FACTOR IN MAN. The Journal of Clinical Endocrinology & Metabolism. 61(6). 1217–1219. 107 indexed citations
8.
Witzgall, H., Reinhard Lorenz, Klaus von Werder, & Christian Weber. (1985). Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. Clinical Science. 68(3). 291–299. 11 indexed citations
9.
Behr, Jürgen, et al.. (1985). Red cell Na+ -K+ transport in various forms of human hypertension. Role of cardiovascular risk factors and plasma potassium.. PubMed. 63 Suppl 3. 63–5. 13 indexed citations
10.
Armanini, Decio, H. Witzgall, Thomas Strasser, & P. C. Weber. (1985). Mineralocorticoid and Glucocorticoid Receptors in Circulating Mononuclear Leukocytes of Patients with Primary Hyperaldosteronism. Cardiology. 72(1). 99–101. 10 indexed citations
11.
Witzgall, H., et al.. (1983). Clinical and biochemical features of patients with aldosterone-producing adenoma and idiopathic hyperaldosteronism. Journal of Molecular Medicine. 61(1). 35–42. 2 indexed citations
12.
Witzgall, H., B. Scherer, & Christian Weber. (1982). Involvement of Prostaglandins in the Actions of Captopril. Clinical Science. 63(s8). 265s–267s. 19 indexed citations
13.
Witzgall, H., et al.. (1979). Aldosterone 18-glucuronide excretion determined with and without chromatography in human hypertensives. Journal of Molecular Medicine. 57(20). 1133–1135. 1 indexed citations
14.
Witzgall, H., et al.. (1977). Verhalten der Plasmareninaktivit�t unter Langzeitbehandlung des Hochdrucks mit Propranolol. Journal of Molecular Medicine. 55(7). 351–353. 1 indexed citations
15.
Klaus, D., et al.. (1976). [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].. PubMed. 101(37). 1357–9. 1 indexed citations
16.
Witzgall, H., et al.. (1974). Abh�ngigkeit der Speichelkonzentration k�rperfremder Stoffe von der Blutwasserkonzentration an dem Modell von f�nf Sulfonamiden. European Journal of Clinical Pharmacology. 7(1). 77–79. 11 indexed citations
17.
Witzgall, H.. (1967). [Gold therapy in chronic joint rheumatism].. PubMed. 8(7). 250–3. 3 indexed citations
18.
Witzgall, H., et al.. (1964). [THE IMPORTANCE OF BINDING TO ALBUMIN, BODY CELLS AND BACTERIA FOR PHARMACODYNAMICS AND EFFECT OF MEDICINAL SUBSTANCES].. PubMed. 148. 511–35. 5 indexed citations
19.
Witzgall, H., et al.. (1955). [Biligrafin excretion in urine as a chromodiagnostic means of liver function].. PubMed. 10(8). 178–81. 1 indexed citations
20.
Witzgall, H.. (1953). [The blood-CSF ratio of drug concentrations, based on studies of better known sulfonamides].. PubMed. 8(27). 643–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. F. Di Francesco Breakdown of academic impact, for papers by Donald D. Smyth Breakdown of academic impact, for papers by JS McLay Breakdown of academic impact, for papers by R E McCaa Breakdown of academic impact, for papers by Hans J. Keim Breakdown of academic impact, for papers by J B Smith Breakdown of academic impact, for papers by Louis Wj Breakdown of academic impact, for papers by F LEENEN Breakdown of academic impact, for papers by Z. Glück Breakdown of academic impact, for papers by G Di Maro
Rankless by CCL
2026